Literature DB >> 10529482

Iron-independent neuronal expression of transferrin receptor mRNA in the rat.

T Moos1, P S Oates, E H Morgan.   

Abstract

Neuronal transferrin receptor protein expression is highly upregulated widely in CNS following iron deficiency. Using the medial habenular nucleus as a model of neuronal transferrin receptor mRNA expression, the present study examined 17-day-old rats subjected to variations in dietary iron. Changing the iron availability resulted in alterations in plasma and cerebrospinal fluid (CSF) levels of transferrin and iron. The iron-binding capacity of transferrin in CSF was exceeded in normal and iron-overloaded rats. In spite of a lowering of the concentration of brain iron by approximately 22% in iron-deficient rats, neuronal transferrin receptor mRNA was not affected when measured by quantitative densitometry. Brain iron and neuronal transferrin receptor mRNA expression was unaltered in iron overloaded rats. The absence of a rise in transferrin receptor mRNA during iron deficiency suggests that neuronal transferrin receptor mRNA expression is regulated by another mechanism than the post-transcriptional regulation mechanism, which has been attributed to cells of non-neural tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529482     DOI: 10.1016/s0169-328x(99)00226-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  7 in total

1.  Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Free Radic Biol Med       Date:  2011-08-30       Impact factor: 7.376

2.  Apotransferrin protects cortical neurons from hemoglobin toxicity.

Authors:  Jing Chen-Roetling; Lifen Chen; Raymond F Regan
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

Review 3.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

4.  Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.

Authors:  Yun Zhang; William M Pardridge
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

Review 5.  The pivotal role of astrocytes in the metabolism of iron in the brain.

Authors:  Ralf Dringen; Glenda M Bishop; Maico Koeppe; Theresa N Dang; Stephen R Robinson
Journal:  Neurochem Res       Date:  2007-06-06       Impact factor: 3.996

6.  Manganese-Enhanced MRI Reflects Both Activity-Independent and Activity-Dependent Uptake within the Rat Habenulomesencephalic Pathway.

Authors:  Leiming Wang; Hanbing Lu; P Leon Brown; William Rea; Bruce Vaupel; Yihong Yang; Elliot Stein; Paul D Shepard
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage.

Authors:  Nuria DeGregorio-Rocasolano; Octavi Martí-Sistac; Jovita Ponce; María Castelló-Ruiz; Mònica Millán; Verónica Guirao; Isaac García-Yébenes; Juan B Salom; Pedro Ramos-Cabrer; Enrique Alborch; Ignacio Lizasoain; José Castillo; Antoni Dávalos; Teresa Gasull
Journal:  Redox Biol       Date:  2017-12-02       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.